Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Immedica Pharma
Immedica Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ammonaps
Phenylbutyrate
1999-12-07
Ornithine carbamoyltransferase deficiency disease
,
Carbamoyl-phosphate synthase i deficiency disease
,
Citrullinemia
,
Amyotrophic lateral sclerosis
Emadine
Emedastine
1999-01-27
Allergic conjunctivitis
Ravicti
Glycerol phenylbutyrate
2015-11-26
2030-2032
Inborn urea cycle disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegzilarginase
lung neoplasms
,
small cell lung carcinoma
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloid leukemia
,
preleukemia
,
neoplasms
,
hyperargininemia
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use